RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 146 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $456,613 | +18.2% | 59,688 | +15.4% | 0.00% | – |
| Q2 2023 | $386,311 | -34.7% | 51,715 | -41.7% | 0.00% | – |
| Q1 2023 | $591,362 | +8.1% | 88,660 | +24.9% | 0.00% | – |
| Q4 2022 | $547,201 | -11.5% | 70,973 | +22.2% | 0.00% | – |
| Q3 2022 | $618,000 | +18.2% | 58,070 | -9.7% | 0.00% | – |
| Q2 2022 | $523,000 | +11.0% | 64,318 | -2.3% | 0.00% | – |
| Q1 2022 | $471,000 | -62.2% | 65,799 | -9.6% | 0.00% | -100.0% |
| Q4 2021 | $1,247,000 | +223.9% | 72,801 | +334.3% | 0.00% | – |
| Q3 2021 | $385,000 | -19.6% | 16,762 | +27.7% | 0.00% | – |
| Q2 2021 | $479,000 | – | 13,122 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CRV, LLC | 733,986 | $16,889,000 | 37.30% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 1,388,889 | $31,958,000 | 5.87% |
| Yong Rong (HK) Asset Management Ltd | 377,000 | $8,675,000 | 5.69% |
| Samsara BioCapital, LLC | 752,939 | $17,325,000 | 2.72% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $34,728,000 | 2.04% |
| Spouting Rock Asset Management, LLC | 52,851 | $1,216,000 | 0.61% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 661,703 | $15,226,000 | 0.43% |
| Laurion Capital Management LP | 3,923,713 | $90,285,000 | 0.38% |
| Casdin Capital, LLC | 548,156 | $12,613,000 | 0.31% |
| Baillie Gifford | 22,061,374 | $507,632,000 | 0.27% |